Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil vs Sildenafil Preference in Erectile Dysfunction
NCT00547092Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tadalafil in erectile dysfunction (ED) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Treatment Preference Question at 26 weeks. Started Oct 2003; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00547092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00547092.